Rules concerning manufacture of clinical drugs to be eased

The Korea Food and Drug Administration says the rules concerning the manufacturing of biological preparations for clinical use and their quality control would be eased in an attempt to ensure better health of subjects and support the nation's biotechnology sector.

In an information session on December 24, a KFDA official said that for biological preparations to be used for clinical trial, ma...